Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Archive
Search for this keyword
Advanced search
Close
More
Main menu
Archive
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 75, Issue 9
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical and epidemiological research
Concise report
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars
Online download statistics by month:
Online download statistics by month: March 2016 to March 2025
Abstract
Full
Pdf
Mar 2016
1457
155
319
Apr 2016
444
92
173
May 2016
248
61
68
Jun 2016
257
50
70
Jul 2016
148
29
49
Aug 2016
979
58
244
Sep 2016
536
60
177
Oct 2016
333
59
89
Nov 2016
222
41
48
Dec 2016
156
19
70
Jan 2017
156
29
73
Feb 2017
197
44
35
Mar 2017
137
40
26
Apr 2017
106
20
14
May 2017
111
19
19
Jun 2017
103
23
21
Jul 2017
155
14
17
Aug 2017
187
12
14
Sep 2017
233
19
23
Oct 2017
180
18
22
Nov 2017
193
30
23
Dec 2017
196
15
14
Jan 2018
256
24
28
Feb 2018
138
14
12
Mar 2018
204
21
14
Apr 2018
175
10
4
May 2018
173
5
4
Jun 2018
222
8
3
Jul 2018
204
10
5
Aug 2018
125
5
4
Sep 2018
116
14
7
Oct 2018
128
6
2
Nov 2018
184
11
10
Dec 2018
143
7
6
Jan 2019
160
9
6
Feb 2019
157
6
2
Mar 2019
173
6
7
Apr 2019
114
2
1
May 2019
136
12
5
Jun 2019
125
3
0
Jul 2019
161
8
2
Aug 2019
100
6
4
Sep 2019
113
6
4
Oct 2019
57
2
6
Nov 2019
126
9
4
Dec 2019
92
6
5
Jan 2020
112
5
4
Feb 2020
80
11
4
Mar 2020
75
2
2
Apr 2020
74
5
4
May 2020
54
1
0
Jun 2020
64
5
3
Jul 2020
90
1
1
Aug 2020
74
2
0
Sep 2020
106
6
1
Oct 2020
88
4
2
Nov 2020
78
6
5
Dec 2020
50
9
9
Jan 2021
105
2
1
Feb 2021
85
3
2
Mar 2021
85
3
1
Apr 2021
83
1
1
May 2021
17
5
4
Jun 2021
4
3
1
Jul 2021
5
0
0
Aug 2021
9
4
1
Sep 2021
6
3
4
Oct 2021
68
4
3
Nov 2021
59
12
1
Dec 2021
37
0
0
Jan 2022
55
9
1
Feb 2022
89
1
0
Mar 2022
83
5
1
Apr 2022
154
2
0
May 2022
96
2
1
Jun 2022
116
4
13
Jul 2022
40
0
0
Aug 2022
91
3
1
Sep 2022
62
1
1
Oct 2022
98
2
0
Nov 2022
60
1
0
Dec 2022
22
2
0
Jan 2023
47
9
3
Feb 2023
81
5
2
Mar 2023
33
2
2
Apr 2023
41
7
2
May 2023
45
2
0
Jun 2023
30
3
0
Jul 2023
12
2
1
Aug 2023
55
4
0
Sep 2023
30
2
0
Oct 2023
45
1
0
Nov 2023
70
2
0
Dec 2023
172
6
0
Jan 2024
66
0
0
Feb 2024
165
9
9
Mar 2024
26
4
1
Apr 2024
72
4
0
May 2024
52
2
0
Jun 2024
63
1
1
Jul 2024
31
3
1
Aug 2024
39
5
2
Sep 2024
43
0
0
Oct 2024
94
3
1
Nov 2024
68
6
1
Dec 2024
54
1
0
Jan 2025
51
1
0
Feb 2025
8
0
0
Mar 2025
11
3
1
Total
14294
1333
1852
Read the full text or download the PDF:
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?